Chemoinformaics analysis of DELPHINIDIN-3-O-BETA-GLUCOSIDE
| Molecular Weight | 500.84 | nRot | 4 |
| Heavy Atom Molecular Weight | 479.672 | nRig | 23 |
| Exact Molecular Weight | 500.072 | nRing | 4 |
| Solubility: LogS | -3.096 | nHRing | 2 |
| Solubility: LogP | -0.198 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 17 |
| nHA | 11 | APOL | 60.8767 |
| nHD | 9 | BPOL | 26.2753 |
| QED | 0.185 |
| Synth | 4.367 |
| Natural Product Likeliness | 2.083 |
| NR-PPAR-gamma | 0.94 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.729 |
| HIA | 0.875 |
| CACO-2 | -6.418 |
| MDCK | 0.00000925 |
| BBB | 0.054 |
| PPB | 0.859342 |
| VDSS | 0.871 |
| FU | 0.16366 |
| CYP1A2-inh | 0.088 |
| CYP1A2-sub | 0.033 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.096 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.174 |
| CYP3a4-inh | 0.008 |
| CYP3a4-sub | 0.005 |
| CL | 7.568 |
| T12 | 0.919 |
| hERG | 0.041 |
| Ames | 0.684 |
| ROA | 0.036 |
| SkinSen | 0.769 |
| Carcinogencity | 0.043 |
| EI | 0.081 |
| Respiratory | 0.038 |
| NR-Aromatase | 0.911 |
| Antiviral | Yes |
| Prediction | 0.802392 |